Dennis Jensen, MD
Gastroenterology · Los Angeles, CANPI 1821017443
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,102 of the $11,836 with a category attached, or 60.0%. 7 manufacturers reported payments, led by Vascular Technology, Inc. at 48.9% of the total. Reporting peaked in 2019 at $8,155 and has fallen 97.1% since, to $233 in 2024.
Across 18 payments — averaging $657.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vascular Technology, Inc.$6K
- Boston Scientific$5K
- Ipsen Biopharmaceuticals, Inc$413
- AstraZeneca$336
- AbbVie$312
- Sanofi$144
- plus $116 from 1 others
Across 13 payments — averaging $9334.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$79K
- Covidien LP$43K
What the payments were for
- Consulting fees$2,60022%
- Speaking & faculty fees$7,10260%
- Travel & lodging$1,0048%
- Food & beverage$1,0949%
- Education$360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vascular Technology, Inc. | 2 | $5,790 |
| Boston Scientific | 6 | $4,725 |
| Ipsen Biopharmaceuticals, Inc | 3 | $413 |
| AstraZeneca | 2 | $336 |
| AbbVie | 3 | $312 |
| Sanofi | 1 | $144 |
| Shire North American Group Inc | 1 | $116 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESOLUTION CLIP$4,617
- ONIVYDE$413
- ANDEXXA$300
- DUPIXENT$144
- GATTEX$116
How this compares
$11,836 in reported general payments places this provider in the 80th percentile of 1,885 gastroenterology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Los Angeles
- Bennett RothLos Angeles$2.8M
- Sammy SaabLos Angeles$1.9M
- Sadeea AbbasiLos Angeles$556K
- Gil MelmedLos Angeles$467K
- Venkataraman MuthusamyLos Angeles$297K
- Caroline HwangLos Angeles$279K
- Adarsh ThakerLos Angeles$241K
- Andres YarurLos Angeles$218K
- Joseph PisegnaLos Angeles$210K
- Steven-Huy HanLos Angeles$194K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.